{"id":"https://openalex.org/W2116293554","doi":null,"title":"Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.","display_name":"Collateral sensitivity to cross-linking agents exhibited by cultured L1210 cells resistant to oxazaphosphorines.","publication_year":1985,"publication_date":"1985-02-01","ids":{"openalex":"https://openalex.org/W2116293554","mag":"2116293554","pmid":"https://pubmed.ncbi.nlm.nih.gov/3967238"},"language":"en","primary_location":{"id":"pmid:3967238","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3967238","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037083093","display_name":"Norman E. Sl\u00e1dek","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N E Sladek","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040985735","display_name":"Joseph E. Low","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J E Low","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5054117719","display_name":"G. J. Landkamer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G J Landkamer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7704,"has_fulltext":false,"cited_by_count":25,"citation_normalized_percentile":{"value":0.69502247,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"45","issue":"2","first_page":"625","last_page":"9"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.774399995803833,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.774399995803833,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.12049999833106995,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.03909999877214432,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cross-resistance","display_name":"cross-resistance","score":0.6610000133514404},{"id":"https://openalex.org/keywords/collateral-sensitivity","display_name":"collateral sensitivity","score":0.7300000190734863},{"id":"https://openalex.org/keywords/oxazaphosphorines","display_name":"oxazaphosphorines","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.9279999732971191},{"id":"https://openalex.org/keywords/crosslinking-agents","display_name":"crosslinking agents","score":0.9340000152587891},{"id":"https://openalex.org/keywords/l1210-cells","display_name":"L1210 leukemia","score":0.9359999895095825},{"id":"https://openalex.org/keywords/p388-leukemia-cells","display_name":"P388 leukemia cells","score":0.9980000257492065},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.550000011920929},{"id":"https://openalex.org/keywords/intracellular-ph","display_name":"intracellular pH","score":0.6980000138282776},{"id":"https://openalex.org/keywords/inorganic-phosphate","display_name":"inorganic phosphate","score":0.9279999732971191}],"concepts":[{"id":"https://openalex.org/C2780017796","wikidata":"https://www.wikidata.org/wiki/Q6456824","display_name":"L1210 cells","level":4,"score":0.8380374908447266},{"id":"https://openalex.org/C79879829","wikidata":"https://www.wikidata.org/wiki/Q5571762","display_name":"Intracellular","level":2,"score":0.7471553683280945},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.6385626196861267},{"id":"https://openalex.org/C2778080818","wikidata":"https://www.wikidata.org/wiki/Q1788422","display_name":"Cross-resistance","level":2,"score":0.5797810554504395},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.5166242718696594},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.4933857023715973},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4498608708381653},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.42867106199264526},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.35024818778038025},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3473174571990967},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.2766790986061096},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1482314169406891}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003432","descriptor_name":"Cross-Linking Reagents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006863","descriptor_name":"Hydrogen-Ion Concentration","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007939","descriptor_name":"Leukemia L1210","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007941","descriptor_name":"Leukemia P388","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D010710","descriptor_name":"Phosphates","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:3967238","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3967238","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"mag:2116293554","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3967238","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.6240000128746033}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":27,"referenced_works":["https://openalex.org/W117874633","https://openalex.org/W1676095416","https://openalex.org/W1905166746","https://openalex.org/W1912270191","https://openalex.org/W1928466038","https://openalex.org/W2001610735","https://openalex.org/W2004596343","https://openalex.org/W2015529066","https://openalex.org/W2022703044","https://openalex.org/W2036754828","https://openalex.org/W2041968020","https://openalex.org/W2054855232","https://openalex.org/W2056179614","https://openalex.org/W2068983531","https://openalex.org/W2087879427","https://openalex.org/W2088394461","https://openalex.org/W2107193632","https://openalex.org/W2124798360","https://openalex.org/W2126028579","https://openalex.org/W2235963441","https://openalex.org/W2261673063","https://openalex.org/W2410843759","https://openalex.org/W2411628023","https://openalex.org/W2414192729","https://openalex.org/W2464754328","https://openalex.org/W2504211947","https://openalex.org/W2886003414"],"related_works":["https://openalex.org/W1570195335","https://openalex.org/W2054855232","https://openalex.org/W2126034089","https://openalex.org/W1969941649","https://openalex.org/W2015529066","https://openalex.org/W2000179471","https://openalex.org/W156052394","https://openalex.org/W1966032528","https://openalex.org/W1509374324","https://openalex.org/W2037059265"],"abstract_inverted_index":{"The":[0,42,64],"sensitivity":[1,86],"of":[2,30,38,51,75,123,147,150],"cultured":[3],"L1210":[4],"and":[5,11,22],"P388":[6],"cells,":[7],"sensitive":[8,70],"(L1210/0,":[9],"P388/0)":[10],"resistant":[12,32,118],"(L1210/CPA,":[13],"P388/CPA)":[14],"to":[15,19,36,49,60,71,119,132,140],"cyclophosphamide":[16],"in":[17,55,78,85,94,101],"vivo,":[18],"five":[20],"oxazaphosphorine":[21],"eight":[23],"nonoxazaphosphorine":[24],"cross-linking":[25],"agents":[26],"was":[27,34,46,68,82,116],"determined.":[28],"Each":[29],"the":[31,39,52,61,76,112,120,124,141,144],"sublines":[33],"cross-resistant":[35,48],"all":[37,50,72],"oxazaphosphorines":[40],"tested.":[41],"P388/CPA":[43],"cell":[44,66,114],"line":[45,67,115],"also":[47],"nonoxazaphosphorines":[53],"but,":[54],"most":[56],"cases,":[57],"not":[58,88],"nearly":[59],"same":[62],"extent.":[63],"L1210/CPA":[65,113],"collaterally":[69],"but":[73],"one":[74],"nonoxazaphosphorines,":[77],"which":[79],"case":[80],"it":[81],"equisensitive.":[83],"Changes":[84],"could":[87],"be":[89],"accounted":[90],"for":[91,127,143],"by":[92,99],"changes":[93,100],"intracellular":[95,102],"pH":[96],"values,":[97],"or":[98,105],"inorganic":[103],"phosphate":[104,108],"acid-soluble":[106],"organic":[107],"concentrations.":[109],"Inasmuch":[110],"as":[111],"specifically":[117],"oxazaphosphorines,":[121],"identification":[122],"phenotypic":[125],"basis":[126,142],"this":[128,148],"resistance":[129],"should":[130],"serve":[131],"identify":[133],"a":[134],"potentially":[135],"important":[136],"determinant":[137],"with":[138],"regard":[139],"oncotoxic":[145],"specificity":[146],"group":[149],"agents.":[151]},"counts_by_year":[{"year":2014,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}